Patient-reported Outcomes in Neuroendocrine Neoplasms: a Prospective Quality of Life and Quality of Care Study Within NETwerk
NCT ID: NCT05268783
Last Updated: 2022-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
1000 participants
INTERVENTIONAL
2018-11-05
2029-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the Functional Outcome and Quality of Life in Sarcoma Patients
NCT05051059
Observational Study on GEP-and Pulm-NET Treated at FPG
NCT06402695
Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours
NCT02853422
Study For Evaluating The Value Of A Multi Biomarker Approach In Metastatic GEP NETs
NCT02630654
Resection of the Primary Tumor vs. Systemic Treatment Alone for Patients With Small Intestinal Neuroendocrine Tumors and Unresectable Metastases: a Europe-wide Study
NCT06787014
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NEN patients
EORTC QLQ-C30, EORTC QLQ-GI.NET21 and satisfaction survey
EORTC QLQ-C30
Quality of life questionnaire that has to be completed every 6 months
EORTC QLQ-GI.NET21
Quality of life questionnaire that has to be completed every 6 months
Satisfaction survey
Questionnaire regarding satisfaction of care that has to be completed on Day 1.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
EORTC QLQ-C30
Quality of life questionnaire that has to be completed every 6 months
EORTC QLQ-GI.NET21
Quality of life questionnaire that has to be completed every 6 months
Satisfaction survey
Questionnaire regarding satisfaction of care that has to be completed on Day 1.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years or older
* Patient should appear in Oncobase
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Antwerp
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
AZ Klina
Brasschaat, Antwerp, Belgium
AZ Monica
Deurne, Antwerp, Belgium
Antwerp University Hospital
Edegem, Antwerp, Belgium
AZ Rivierenland
Rumst, Antwerp, Belgium
VITAZ
Sint-Niklaas, East-Flanders, Belgium
ZNA
Antwerp, , Belgium
GZA
Antwerp, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Isolde Van der Massen
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Wim Demey
Role: primary
Laura Wuyts
Role: primary
Timon Vandamme
Role: primary
Marijke Ulenaers
Role: primary
Willem Lybaert
Role: primary
Frank Van Fraeyenhove
Role: primary
Isabelle Maurissen
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Quali-NET
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.